Sun, Mar 1, 2015, 2:24 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Repligen Corporation Message Board

vivirenmiami 1 post  |  Last Activity: Feb 11, 2015 7:02 AM Member since: Dec 11, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • vivirenmiami vivirenmiami Feb 11, 2015 7:02 AM Flag

    I think the earnings per share for the 4th quarter might be higher due to the one million dollar infusion from Pfizer on December 31.

    This amounts to an additional 3 cents a share. Last year RGEN received infusions of three million dollars from their drug platforms. This amounts to 10 cents a share. Without that money their EPS for 2014 would be about 20 cents.

    RGEN's drug platform is likely finished. No more cash infusions. Nevertheless RGEN should earn about 30 cents a share in 2015.

    There is a little cooking of the books. RGEN's European revenue is subject to full income taxes. RGEN's United States income benefits from past tax loses. More than likely RGEN is paying very little taxes on its USA income. If RGEN paid full taxes on their USA income, the earnings for RGEN would be reduced. The 20 or 30 cents per share earnings reported by RGEN may be a little rosier than they would be without the tax loss benefit.

25.71-0.49(-1.87%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.